A game-changing breakthrough in women’s health is on the horizon. Australian biotech firm Proteomics International is set to launch the world’s first blood test for endometriosis this year.
A Leap Forward: In a rigorous, peer-reviewed study involving 749 participants, researchers at Proteomics identified 10 distinct protein biomarkers linked to the condition. Their cutting-edge PromarkerEndo test demonstrated over 85% accuracy for early detection and an impressive 99.7% accuracy for severe cases.
The Hidden Epidemic: Endometriosis, a painful and often debilitating condition, affects 1 in 10 women worldwide—around 190 million people—yet remains alarmingly underdiagnosed. Beyond chronic pain, it can lead to infertility and significantly impact quality of life.
On average, it takes seven years for a diagnosis, delaying crucial treatment. Earlier detection could open doors to noninvasive treatment options, potentially reducing the need for surgery.
The Future of Women’s Health: With global patents in progress and an imminent Australian launch, the PromarkerEndo test is poised to redefine endometriosis care. As part of a new wave of innovative diagnostics, this test represents a major step forward in closing the care gap and improving outcomes for millions.
Source: https://insider.fitt.co/new-blood-test-detects-endometriosis/